Form 4: HealthEquity Executive Stephen Neeleman Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Stephen Neeleman, a Director and Officer of HealthEquity, Inc., executed stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On July 25, 2024, Stephen Neeleman, a Director and Officer (Founder and Vice Chairman) of HealthEquity, Inc. (HQY), engaged in transactions involving the company's common stock.
- Neeleman exercised stock options to acquire 35,000 shares of common stock at an exercise price of $14.
- Simultaneously, he sold 35,000 shares of common stock at weighted average prices of $79.7314 and $80.1505 per share, respectively, under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2023.
- Following these transactions, Neeleman directly owns 89,769 shares of common stock.
- He also indirectly owns 559,235 shares through the Stephen and Christine Neeleman Trust and 203,000 shares through Neeleman Family Holdings, LLC.
- Neeleman disclaims beneficial ownership of shares held by Neeleman Family Holdings, LLC except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy, suggesting no immediate cause for alarm or excessive optimism. The executive is realizing value from stock options, which is a normal part of executive compensation.
Positives
- The execution of stock options and subsequent sale of shares occurred under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and compliant practice.
Industry Context
Insider transactions are common, and the use of a 10b5-1 plan suggests a structured approach to avoid accusations of trading on inside information. Investors often monitor these filings for insights into management's perspective on the company's value.
Comparison to Industry Standards
- Executive compensation packages often include stock options as incentives, aligning management's interests with shareholders.
- Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock holdings in a compliant manner.
- The size of the transaction is not unusual for an executive of Neeleman's position.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership structure.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2023-12-08 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-07-25 | Date of stock option exercise and share sale. |
| 2024-07-26 | Date of Form 4 signature. |
| 2024-07-30 | Expiration date of some stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.